Back to Authors

Amonkar, Mayur M.

A5143996482 | I1285764155

Mayo Clinic

Merck & Co., Inc., Rahway, NJ, USA (United States)

Citations 1

Real-world effectiveness of pembrolizumab for first-line treatment of metastatic non-small-cell lung cancer: a decade of evidence and experience

Future Oncology | July 30, 2026 | Volume: No volume available | Issue: No issue available | Pages: 1-20

10.1080/14796694.2026.2709201 | PMID 42528479